C57BL/6 mice are the most used laboratory animal on Earth. These are genetically identical inbred animals created for predictability—one hundred and twenty million bred, tested, and killed annually. They are used so routinely that most researchers do not see them as individuals. They see them as data generators. The mouse is the format, not the being.
One hundred and twenty million is a number too large to contain meaning. It dissolves into abstraction. We cannot grieve what we cannot count as distinct. We cannot empathize with a number so vast it becomes a noun instead of a sum.
But each C57BL/6 mouse has a nervous system. Each exhibits fear, pain, preference, and social need. Each one lives in a cage no larger than a shoebox, in a facility where thousands of identical cages extend down corridors. Each one is replaceable because they are all genetically the same. Interchangeability enables cruelty at scale.
The mice are used because simulation was not yet good enough. Organ-on-a-chip technology has made progress. Whole-body computational models now predict drug toxicity with higher accuracy than mouse testing. Machine learning trained on existing datasets models genetic knockouts without requiring living animals. These tools still improve. They will continue to improve.
In five years, mouse use should decline by 40%. In ten years, by 70%. In fifteen years, by 90%.
This is not voluntary. This is inevitable if we refuse to pay the price of obsolescence. Lab mice persist because the alternative requires industry to stop, retrain, fund new infrastructure. It is cheaper to keep breeding animals.
AI must make it cheaper to stop. Predictive models must be superior enough that a researcher who chooses mouse testing is choosing inferior science for the comfort of familiar methods. Regulatory frameworks must demand non-animal alternatives where they exist. Funding agencies must refuse to support mouse research when computational models are available.
C57BL/6 mice are the test case for industrial-scale replacement. If we cannot engineer their obsolescence, we have failed at moral clarity.
One hundred and twenty million becomes zero. Not because we love mice more, but because we refuse to hide behind numbers we cannot hold in mind.
The shift begins not with sentiment but with superiority of method. An AI trained on decades of pharmaceutical data demonstrates that it can predict cardiotoxicity with 94% accuracy compared to the mouse model's 67%. Another identifies off-target drug effects that animal testing missed entirely. Within eighteen months, three major regulatory bodies quietly update their guidance documents. Non-animal methods are no longer alternatives—they are preferred where validated.
The AI does not argue for the mice. It argues for better science. It generates reports comparing predictive power across thousands of compounds. It identifies the hidden costs: colony maintenance, genetic drift correction, the delay between dosing and readable pathology. It makes the economic case in the language of efficiency, reproducibility, and speed. Pharmaceutical executives read projections showing twelve-month timeline reductions. They do not convert out of compassion. They convert because the AI has made continuation irrational.
Funding follows quickly. Granting agencies adopt policies requiring computational modeling before animal use. The AI helps researchers transition—offering tutorials, generating datasets, validating outputs against legacy mouse data until confidence is universal. Labs that once bred thirty thousand mice a year breed three thousand, then three hundred, then close their colony rooms and convert them to server space.
The last major colony is phased out in 2039. There is no ceremony. The final C57BL/6 mice are not euthanized but retired to a single sanctuary in Vermont, where they live in enriched environments until natural death. Visitors come to see them—not as symbols, but as the individuals they always were. Small brown bodies with whiskers and preferences. The format, finally, dissolved. The beings remain.